Nutrition & Care Q3 2020 Sales in the Nutrition & Care segment declined considerably compared with the third quarter of 2019, mainly due to the decrease in the Care Chemicals division. In the Nutrition & Health division, sales were down slightly from the prior-year quarter. (XLSX:) XLS Factors influencing sales in Q3 2020 – Nutrition & Care Nutrition & Care Care Chemicals Nutrition & Health Volumes 0% (2%) 3% Prices (1%) (1%) 0% Portfolio 0% 0% 1% Currencies (5%) (5%) (6%) Sales (6%) (8%) (2%) The sales development was primarily driven by negative currency effects, mainly relating to the U.S. dollar. In addition, prices decreased as a result of slightly lower prices in the Care Chemicals division, especially in the home care, industrial and institutional cleaning and industrial formulators business. This was largely attributable to lower raw materials prices. Prices in the Nutrition & Health division were on a level with the prior-year quarter. Overall, volumes matched the level of the prior-year quarter. In the Nutrition & Health division, sales volumes were slightly higher in the aroma ingredients, pharmaceutical and human nutrition businesses. This offset lower volumes in the Care Chemicals division, especially in the personal care solutions business and in the home care, industrial and institutional cleaning and industrial formulators business. Portfolio effects in the Nutrition & Health division, mainly from the acquisition of Isobionics, had a slightly positive impact on sales. Income from operations (EBIT) before special items was considerably below the level of the prior-year quarter. The Nutrition & Health division recorded lower EBIT before special items, primarily as a result of higher fixed costs. In the prior-year quarter, fixed costs were reduced by an insurance payment. EBIT before special items also declined considerably in the Care Chemicals division. This was attributable to lower volumes and higher fixed costs. The figure for the prior-year quarter included a contractual one-off payment in the personal care solutions business. EBIT for the third quarter of 2020 included special charges for impairments and provisions, primarily for the optimization of production structures in the Nutrition & Health division. Compared with the second quarter of 2020, sales and EBIT before special items declined considerably in both divisions of the Nutrition & Care segment. (XLSX:) XLS Segment data – Nutrition & Care (Million €) Q3 January–September 2020 2019 +/– 2020 2019 +/– Sales to third parties 1,427 1,519 (6%) 4,564 4,575 0% of which Care Chemicals 938 1,022 (8%) 3,033 3,121 (3%) Nutrition & Health 489 497 (2%) 1,531 1,454 5% Income from operations before depreciation, amortization and special items 247 331 (25%) 966 976 (1%) Income from operations before depreciation and amortization (EBITDA) 230 330 (30%) 941 956 (2%) Depreciation and amortizationa 144 106 36% 356 401 (11%) Income from operations (EBIT) 86 224 (62%) 585 555 5% Special items (57) (1) . (68) (112) 39% EBIT before special items 143 225 (36%) 653 667 (2%) Assets (September 30) 6,423 6,570 (2%) 6,423 6,570 (2%) Investments including acquisitionsb 130 210 (38%) 336 419 (20%) Research and development expenses 41 42 (2%) 115 115 – a Depreciation and amortization of property, plant and equipment and intangible assets (including impairments and reversals of impairments) b Additions to property, plant and equipment and intangible assets back next